Managing Editor
@ShahidNShah
@ShahidNShah
How AI is Advancing Cancer Diagnosis
As AI gains traction in healthcare, it is demonstrating enormous potential to transform cancer diagnostics and serve as a powerful partner to pathologists—many of whom have been using glass slides and microscopes for over 150 years. They sat down with Paige CEO, Razik Yousfi, to learn more. Paige is recognized for its industry-leading AI technology, regulatory approvals, and development of the largest foundation models in pathology, built upon one of the world’s most comprehensive databases originating from a world-renowned cancer center. As one of the first to bring novel AI technology and integrated diagnostics into clinical pathology, Paige is shaping the future of cancer detection.
Medigy Insights
The capabilities of Paige’s Virchow Foundation Models were highlighted in a recent publication in Nature Medicine. And, for about five years before any competitor, Paige was the only company in this space with FDA approval—largely due to the extensive, representative, and unbiased data used in its models. Paige’s latest foundation models were trained on de-identified data from more than 225,000 patients, representing a broad spectrum of gender, race, ethnicity, and geographic diversity. This diversity ensures that the technology is generalizable and equitable, reducing disparities in diagnosis and meeting the highest regulatory standards for ethical AI in healthcare.
Continue reading at healthcareittoday.com
Make faster decisions with community advice
Next Article
-
Can Generative AI Tackle Global Health Problems?
Generative AI, a type of large language model that underlies artificial intelligence chatbots like ChatGPT, could have a lot to offer in low- and middle-income countries where access to reliable …
